Humira Pen (5402)

Description

Humira® Pen (adalimumab) 40 mg/0.8 mL – Prefilled Autoinjector Pen (Product Code 5402)

Product Description:
Humira® is a monoclonal antibody that targets and inhibits tumor necrosis factor (TNF), a protein involved in inflammation. Humira is indicated for the treatment of various autoimmune conditions, including rheumatoid arthritis, psoriasis, Crohn’s disease, and ulcerative colitis. The Humira Pen (5402) is a prefilled autoinjector that offers self-administration with ease and convenience for adult patients requiring subcutaneous therapy.

Product Features:

• Active Ingredient: Adalimumab

• Strength: 40 mg/0.8 mL per injection

• Dosage Form: Prefilled autoinjector (Humira Pen)

• Presentation: Single-dose pen containing 40 mg adalimumab in 0.8 mL solution

• Route of Administration: Subcutaneous injection

• Administration Frequency: Varies by condition; typically biweekly or weekly

Indications:

• Rheumatoid arthritis (RA) in adults

• Psoriasis (moderate to severe plaque psoriasis)

• Crohn’s disease

• Ulcerative colitis

• Ankylosing spondylitis

• Psoriatic arthritis

• Hidradenitis suppurativa

• Juvenile idiopathic arthritis (JIA) in children 2 years and older